Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto—GBG 84): A randomised phase III trial
Titel:
Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto—GBG 84): A randomised phase III trial
Auteur:
Schneeweiss, Andreas Möbus, Volker Tesch, Hans Hanusch, Claus Denkert, Carsten Lübbe, Kristina Huober, Jens Klare, Peter Kümmel, Sherko Untch, Michael Kast, Karin Jackisch, Christian Thomalla, Jörg Ingold-Heppner, Barbara Blohmer, Jens-Uwe Rezai, Mahdi Frank, Matthias Engels, Knut Rhiem, Kerstin Fasching, Peter Andreas Nekljudova, Valentina von Minckwitz, Gunter Loibl, Sibylle